New research from charity Parkinson’s UK and Sheffield Hallam University, UK, has revealed that thousands of people affected by Parkinson’s are struggling with financial losses of more than £16,000 each year
Thousands of people affected by Parkinson’s are struggling with financial losses of more than £16,000 every year, according to new research published by Sheffield Hallam University and Parkinson’s UK.
The report – ‘The Cost of Parkinson’s: the financial impact of living with the condition’ – shows that a household where a person is living with the condition loses an average of £319 per week due to reduced income plus an increase in living costs. This is 60% more than previously thought.
Half of those diagnosed with Parkinson’s, and one third of their family members, have reduced working hours. Overall, households affected by the condition experience a reduction of income averaging more than £10,000 per year.
The hidden price of Parkinson’s is a result of:
– being unable to work or having to take early retirement (£6,013)
– a reduction in working hours by the person affected and/or by their carer (£1,981)
– family members providing unpaid care without financial support (£1,235)
– discontinuance of state benefits and pensions (£1,502)
– mounting health and social care costs, which total an average of £5,851 per year:
assistance for daily living, such as transport and personal care (£2,088)
energy costs (£572)
healthcare related equipment and travel (£1959)
adaptations to the home (£525).
Steve Ford, chief executive at Parkinson’s UK, said: “For the first time, this research has exposed the full financial impact of Parkinson’s, and it’s shocking that people affected by the condition are being hit by such devastating losses – especially at a time when families are already feeling the strain.
“People are being penalised by heavily reduced incomes and forced to pay for a lifetime of mobility aids, home alterations and care costs – all while battling a debilitating progressive condition, for which there is no cure.”
Anna Cunningham is 46 and lives in Dundee, Scotland. She was diagnosed with Parkinson’s in 2013 and was forced to retire from her role as healthcare assistant, due to her symptoms.
Anna said: “Being diagnosed with Parkinson’s was a total shock. I was told I needed to retire early and it hit me like a ton of bricks.
“I have a small NHS pension, which brings in about £200 a month, and my husband works part time at the hospital, so financially it was very hard straight away.”
The report also highlights a reduction in quality of life for people with Parkinson’s as the condition progresses. Most respondents with Parkinson’s had seen a decline in their health over the previous year, with two-thirds needing help with activities inside and outside the home.
In addition, it showed a worrying impact on general wellbeing. More than 60% of people with Parkinson’s and 55% of carers who were questioned, reported low life satisfaction.
Parkinson’s UK is calling on the government to make changes to welfare support and increase social care investment, as well as proposing new policies and practices for employers, to help people affected by Parkinson’s stay in work for as long as possible.
Steve Ford continued: “This report has uncovered an impossible scenario being faced by thousands of people affected by Parkinson’s. Every day, people are being forced to choose between being out of pocket, or sacrificing their health – and it’s having a significant impact on their wellbeing. More must be done to address inconsistencies in services and funding available to households affected by the condition across the UK.
“With a stretched NHS and social care services, and changes to welfare support, it is crucial that the government works with us, and people affected by Parkinson’s, to develop solutions and improve the public services we all rely on.”
Dr Anil Gumber, principal investigator at Sheffield Hallam University’s Faculty of Health and Wellbeing, said: “People affected by Parkinson’s and their informal carers, need support from the point of diagnosis to better understand the condition, and help plan how they cope in the long term.
“Our research has highlighted that there continue to be inconsistencies in the provision of services, and funding accessible to people with Parkinson’s across the UK and this needs to be rectified to ensure there is consistent provision of care from diagnosis across the health, social care and independent sectors.”
Image credits: Parkinson’s UK
Read and/or download the full report from the Parkinson’s UK website
Global Parkinson’s study reveals sleep as biggest influence on wellbeing
First insights revealed from data gathered by smartphones
6 hours ago
Study suggests why neurons die in Parkinson’s disease
Researchers at the University of Córdoba, Spain, have discovered how a certain protein may be linked to death of dopamine-producing neurons associated with Parkinson’s. Using animal models of the condition to conduct their study, the team focused on the protein DJ-1 – whose link to Parkinson’s has previously been established, though its exact function was uncertain. The researchers compared neurons in the brains of mice that possessed the gene expressing DJ-1 with those that did not. The findings revealed that dysfunction or absence of the gene expressing the DJ-1 protein could trigger the ‘cell cycle’ (the process by which cells divide), which should not occur under normal conditions. Because neurons lack the capacity to divide, this causes them die – leading to the onset of symptoms linked with Parkinson’s. It is hoped that uncovering these details about the relationship between DJ-1’s absence and Parkinson’s may lead to the development of…
Researchers have finally identified brain cells linked to Parkinson’s disease
For decades, scientists have known that Parkinson’s is associated with the death of dopamine-producing cells in the brain. Now, researchers from the Broad Institute of MIT and Harvard, US, have discovered the specific subtype of brain cells that die in Parkinson’s disease. Using a technique called single-cell RNA signalling, which enables the individual analysis of cells within a tissue for activity and protein production, researchers identified 10 subtypes of dopamine-producing cells within the donated brains of people who died from causes unrelated to Parkinson’s. The team carried out the same investigation on people who had died with Parkinson’s or a condition with similar symptoms called Lewy body dementia. They discovered that only one subtype of the cells had reduced in number – which suggests many of these cells had died while the people were living. It is hoped that the findings could lead to better understanding of Parkinson’s causes and…
Tiny DBS implant shows potential to advance Parkinson’s disease treatment
In an innovative trial by North Bristol NHS Trust, UK, surgeons have succeeded in implanting a tiny deep brain stimulation (DBS) device into a person’s skull. Their aim? To address symptoms of Parkinson’s. Designed with a tiny battery system that is inserted into the skull, the DBS device delivers electric impulses to targeted areas of the brain through electric probes. In doing so, it works to address abnormal brain cell activity associated with Parkinson’s – and may help to ease symptoms. One of around 25 patients selected for the year-long trial has described the device’s impact as “amazing”. Commenting on the results of the trial so far, consultant neurologist Dr Alan Whone of North Bristol NHS Trust said: “We are hopeful that if these findings hold up, we will have a significant technical advance by which to improve Parkinson’s care across the world.”